Skip to main content
Fig. 2 | Microbiome

Fig. 2

From: Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo

Fig. 2

Effect of synergistic probiotics on lovastatin in vitro experimental design. A Schematic diagram showing experimental design. The date of constructing mixed hyperlipidemia model was defined as the baseline, on which golden hamsters were fed with high-fat diet. Lovastatin, lovastatin plus probiotics were administered daily from week 8 to week 12 (Lov group, L + A5 group, L + C3 group, and L + LcS group), and the MO group was replaced by carboxymethyl cellulose. The golden hamsters were killed in the 12th week. At the 8th week and the 12th week, fecal samples were collected for shotgun metagenomic sequencing, and serum was collected for blood index detection. At the 12th week, liver tissues were collected for the determination of liver transcriptome and liver tissue sections, and intestinal contents were collected for the determination of SCFAs

Back to article page

Microbiome

ISSN: 2049-2618

Contact us